1. B. M. Alving, D. L. Tankersley, B. L. Mason, F. Rossi, D. L. Aronson and J. S. Finlayson,Contact activated factors: contaminants of immunoglobulin preparations with coagulant and vasoactive properties. J. Lab. Clin. Med.96, 334–346 (1980).
2. W. K. Bleeker, R. F. Rosevelt van, J. G. R. Ufkes, J. A. Loos, J. A. Mourik and J. C. Bakker,Hypotensive effect of plasma protein fraction: the relation between pre-kallikrein activator, bradykinin generation and blood pressure in an animal model. J. Lab. Clin. Med.100, 540–547 (1982).
3. W. K. Bleeker, J. Agterberg, A. de Vries-van Rossen and J. C. Bakker,An animal model for the detection of hypotensive side effects of immunoglobulin preparations. Vox Sang.52, 281–290 (1987).
4. B. Boros,Preparation of immunoglobulin G in connection with a two-step albumin isolation. InSeparation of plasma proteins. pp. 135–140 (Ed. J. M. Curling) Pharmacia Fine Chemicals, Uppsala 1983.
5. P. Kistler, H. Isliker and S. Barandun,Preparation of human globulin for intravenous application. Abstr. 9th Cong. Int. Soc. Blood Transfusion,, Mexico City 1962, 41 p.